ANAHEIM, Calif. —

  • 1 Related

    Scherzer, a three-time Cy Young Award winner who signed a one-year, $15.5 million deal with Toronto in February, threw 20 pitches. Barring a setback, Schneider said he would repeat the workout but with more pitches over the weekend.

    “It felt good,” Scherzer, 40, said. “I’ve gotten all the inflammation out, so I can finally grip the ball again and not blow out my shoulder. But I’m not celebrating this until I’m back starting in a major league game.”

    Scherzer has received two cortisone injections to relieve inflammation in the thumb this season. He was transferred to the 60-day injured list earlier this week and is not eligible to be activated until May 29.

    He went 2-4 with a 3.95 ERA in nine starts for Texas last season, starting the year on the injured list while recovering from lower back surgery. He said Tuesday that his problematic right thumb, which also affected his 2022 and 2023 seasons, was just as big of an issue in 2024.

    “This is what knocked me out in 2023, and [I had it] all of last year,” Scherzer said. “It wasn’t so much the back injury, it was this thumb injury giving me all the fits in the world. I thought I addressed it. I thought I had done all the grip-strength work, but I came into spring training, and it popped back out.”

    Scherzer left his debut start with the Blue Jays against Baltimore on March 29 after three innings because of soreness in his right lat muscle. He said after the game that his thumb issue was to blame for that soreness.